Lp-PLA2 Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus.
Titin Andri WihastutiFitria Nugraha AiniCholid Tri TjahjonoYuni Hendrati SulfiaZuhrotus SholichahTeuku HeriansyahPublished in: Vascular health and risk management (2019)
Our results show that atherosclerosis caused by inflammation in renal T2DM SD rats could be inhibited by the administration of darapladib.